Physician CEOs keep a $172,000 pay premium in health system medical groups
Physician leadership still commands a premium in the executive suite of health system-owned medical groups. In SullivanCotter’s latest compensation survey, physician presidents and CEOs posted a median total cash compensation of $902,400 in 2026, while non-physician counterparts came in at $730,400. The spread was about $172,000, or 24%, and it remained remarkably stable year over year.
The gap was nearly the same in base pay. Physician CEOs earned a median base salary of $697,400, compared with $560,600 for non-physician CEOs, a difference of about $137,000. For health systems weighing whether the chief executive should come from a clinical background, the compensation signal is hard to miss: physician leadership is paid more, and the market has not meaningfully closed that distance.
Incentive pay, not base salary, is doing most of the work
The median base salary increase was slightly stronger for physician CEOs, rising 4.9% compared with 3.5% for non-physician CEOs. Yet non-physician leaders posted the faster rise in total cash compensation, up 9.6% at the median versus 7.9% for physician CEOs. The explanation sits in incentive pay, where the year-over-year expansion was larger for the non-physician group.
For non-physician CEOs, the gap between median total cash compensation and median base salary widened from about $124,000 to about $170,000, a jump of roughly 36%. For physician CEOs, the same spread grew from about $172,000 to about $205,000, or roughly 19%. Incentive data reflects the 2025 performance year, while base salaries were effective Jan. 1, 2026. In practical terms, the executive bonus structure, rather than the salary floor, is what is shaping the final compensation differential.
One sentence captures the entire pay story: the physician premium stayed flat in dollars even as both groups moved higher.
A narrow dataset, but a revealing one
The analysis drew from SullivanCotter’s 2025-2026 Health Care Management and Executive Compensation Survey Report and included 48 physician CEOs and 30 non-physician CEOs at subsidiary medical groups operating within larger health systems. Only organizations that participated in both the 2025 and 2026 survey editions were included. That design provides a view of compensation movement across consecutive survey cycles, but it is not a same-incumbent analysis, so changes may reflect hiring shifts, promotions, organizational restructuring, or a different executive occupying the seat.
That limitation should temper any attempt to interpret the year-over-year movement as a pure pay raise for the same person. It is still useful for showing how the market values the role itself. Even with a changing executive roster, the physician premium remained almost exactly where it had been: about $170,000 in 2025 and about $172,000 in 2026, slipping slightly from roughly 26% to 24% as a percentage of total cash compensation.
Mean figures told the same story. Average total cash compensation was $916,300 for physician CEOs and $763,600 for non-physician CEOs, with year-over-year increases of 9.4% and 9%, respectively. The similarity in average growth suggests that broad compensation inflation is affecting both groups, while the persistent absolute premium continues to favor physician leaders.
Clinical integration is increasingly an executive skill, and health systems are paying for it
SullivanCotter framed the pay pattern within a wider movement across health system leadership: compensation is rising fastest in roles tied to clinical integration, physician alignment, and growth. Medical groups sit at the center of all three. They connect employed physicians to hospital strategy, anchor referral networks, and carry much of the operational burden of ambulatory expansion, care standardization, and quality management.
That operational complexity helps explain why physician CEOs continue to receive a higher market value. A physician executive often brings firsthand knowledge of clinical workflow, care variation, and the practical realities of physician engagement. In health systems where success depends on aligning employed clinicians with enterprise goals, that background can translate into leverage at the bargaining table. The compensation premium may reflect not just credentialing, but the premium placed on someone who can speak both the language of medicine and the language of system growth.
The structure of the incentive gap also matters. When annual bonuses make up a larger share of total cash compensation, they reveal what organizations are rewarding in real time. In these medical group roles, the larger movement in incentive dollars points toward performance metrics tied to integration and expansion rather than static leadership tenure.
What the compensation data can and cannot tell health systems
The numbers do not prove that physician CEOs perform better than non-physician CEOs, and they do not isolate the effect of degree alone. Compensation surveys measure market behavior, not leadership quality. Still, the pattern is clinically and operationally relevant because it reflects how health systems are pricing executive influence over physician enterprises that now drive much of outpatient care delivery.
The physician premium is also not exploding. It is holding steady in dollar terms, even as total compensation rises for both groups. That steadiness suggests a mature market rather than a sudden revaluation of the physician executive role. Systems looking for a physician leader are still paying more, but they are not paying a vastly different premium than they were a year earlier.
For boards and executive search committees, the practical question is less about whether physician CEOs are more expensive—they are—and more about where that added cost is justified. As medical groups expand in size and complexity, the executive role has become tightly linked to physician alignment, clinical operations, and enterprise growth. Compensation is tracking that reality one survey cycle at a time, and the latest numbers show the premium remains firmly in place.